In contrast to successes for multiple sclerosis (MS) susceptibility, the genetic basis for clinical heterogeneity remains largely unresolved.
Objectives:
We investigate the first reported genetic association with relapse rate.
Methods:
We genotyped variant rs12988804 in LRP2 in a homogeneous study population of 527 Belgian MS patients with 970 documented relapses.
Results:
The rs12988804*T allele is associated with a 1.16-fold increased hazard rate for a relapse occurring (P = 0.0078) and a higher baseline relapse rate prior to immunomodulatory treatment (P = 0.044).
Conclusion:
Variant rs12988804 in LRP2, the first example of a genome-wide significant association with relapse rate in MS, is replicated in an independent study.
The International Multiple Sclerosis Genetics Consortium. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis. Nat Genet2013; 45: 1353–1360.
2.
The International Multiple Sclerosis Genetics Consortium and The Wellcome Trust Case Control Consortium 2. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature2011; 476: 214–219.
3.
MoutsianasLJostinsLBeechamAHet al. Class II HLA interactions modulate genetic risk for multiple sclerosis. Nat Genet2015; 47: 1107–1113.
4.
LongbrakeEEHaflerDA.Linking genotype to clinical phenotype in multiple sclerosis: In search of the holy grail. JAMA Neurol2016; 73: 777–778.
5.
ZhouYGravesJSSimpsonSet al. Genetic variation in the gene LRP2 increases relapse risk in multiple sclerosis. J Neurol Neurosurg Psychiatry2017; 88: 864–868.
6.
HilvenKPatsopoulosNADuboisBet al. Burden of risk variants correlates with phenotype of multiple sclerosis. Mult Scler2015; 21: 1670–1680.
7.
LeeJCBiasciDRobertsRet al. Genome-wide association study identifies distinct genetic contributions to prognosis and susceptibility in Crohn’s disease. Nat Genet2017; 49: 262–268.
8.
BuckDAlbrechtEAslamMet al. Genetic variants in the immunoglobulin heavy chain locus are associated with the IgG index in multiple sclerosis. Ann Neurol2012; 73: 86–94.
9.
GorisAPauwelsIGustavsenMWet al. Genetic variants are major determinants of CSF antibody levels in multiple sclerosis. Brain2015; 138: 632–643.
10.
SondergaardHBPetersenERMagyariMet al. Genetic burden of MS risk variants distinguish patients from healthy individuals but are not associated with disease activity. Mult Scler Relat Disord2017; 13: 25–27.
